Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | breakpoint cluster region | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | active breakpoint cluster region | Get druggable targets OG5_131841 | All targets in OG5_131841 |
Echinococcus multilocularis | active breakpoint cluster region | Get druggable targets OG5_131841 | All targets in OG5_131841 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.1409 | 0.3259 |
Echinococcus granulosus | synaptojanin 1 | 0.0004 | 0.0178 | 0.0178 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.2662 | 0.6575 |
Echinococcus granulosus | CCR4 NOT transcription complex subunit 6 | 0.0004 | 0.0178 | 0.0178 |
Onchocerca volvulus | Putative neutral sphingomyelinase | 0.0004 | 0.0178 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.116 | 0.1201 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.1409 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0016 | 0.116 | 0.116 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.116 | 0.1201 |
Onchocerca volvulus | 0.0004 | 0.0178 | 0.5 | |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.1409 | 0.1409 |
Echinococcus granulosus | neutral sphingomyelinase | 0.0004 | 0.0178 | 0.0178 |
Echinococcus multilocularis | GPCR, family 2 | 0.0016 | 0.116 | 0.116 |
Echinococcus multilocularis | active breakpoint cluster region | 0.0122 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.1409 | 0.5 |
Echinococcus multilocularis | traf and tnf receptor associated protein | 0.0004 | 0.0178 | 0.0178 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0016 | 0.116 | 0.2601 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.3956 | 1 |
Trypanosoma brucei | inositol/phosphatidylinositol phosphatase, putative | 0.0004 | 0.0184 | 0.0008 |
Trypanosoma brucei | RNA helicase, putative | 0.0102 | 0.8357 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.116 | 0.1201 |
Onchocerca volvulus | 0.0004 | 0.0178 | 0.5 | |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.3956 | 1 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0.1409 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0016 | 0.116 | 0.116 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.3956 | 1 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.1409 | 0.1505 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0016 | 0.116 | 0.116 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.1409 | 0.1505 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.1409 | 0.1409 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.2662 | 0.3037 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0016 | 0.116 | 0.2601 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.1409 | 0.3259 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0004 | 0.0178 | 0.0178 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.2662 | 0.6575 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0016 | 0.116 | 0.116 |
Echinococcus multilocularis | neutral sphingomyelinase | 0.0004 | 0.0178 | 0.0178 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.1409 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.1409 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0102 | 0.8357 | 1 |
Echinococcus multilocularis | inositol polyphosphate 5 phosphatase OCRL 1 | 0.0004 | 0.0178 | 0.0178 |
Echinococcus granulosus | GPCR family 2 | 0.0016 | 0.116 | 0.116 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.3956 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.1409 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.116 | 0.1201 |
Echinococcus multilocularis | CCR4 NOT transcription complex subunit 6 | 0.0004 | 0.0178 | 0.0178 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0019 | 0.1409 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0019 | 0.1409 | 1 |
Echinococcus granulosus | traf and tnf receptor associated protein | 0.0004 | 0.0178 | 0.0178 |
Echinococcus multilocularis | synaptojanin 1 | 0.0004 | 0.0178 | 0.0178 |
Echinococcus granulosus | inositol polyphosphate 5 phosphatase OCRL 1 | 0.0004 | 0.0178 | 0.0178 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.1409 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0.1409 | 0.5 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0019 | 0.1409 | 1 |
Leishmania major | inositol/phosphatidylinositol phosphatase, putative | 0.0004 | 0.0184 | 0.0051 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.1409 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.1409 | 1 |
Echinococcus multilocularis | deoxyribonuclease 1 2 | 0.0004 | 0.0178 | 0.0178 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.1409 | 0.1505 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.116 | 0.2601 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0004 | 0.0178 | 0.0178 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0016 | 0.116 | 0.2601 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.1409 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 0.15 uM | Inhibition of Bcr-Abl in mouse BA/F3 cells | ChEMBL. | 20828158 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.